GU Research Network/Urology Cancer Center — Omaha, Nebraska

GU Research Network/Urology Cancer Center is a clinical research site located in Omaha, Nebraska, United States 68130.

Crixeo Clinical Trials Trust Score: 20/100 (FAILING). This profile has not yet been claimed by the site owner.

GU Research Network/Urology Cancer Center has participated in 13 clinical trials with 3 currently active.

Therapeutic areas: Metastatic Castration-Resistant Prostate Cancer, UC (Urothelial Cancer), Renal Cell Carcinoma.

Sponsors: Xencor, Inc., Incyte Corporation, Xynomic Pharmaceuticals, Inc..

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Omaha

Browse all research sites in Nebraska · View every site in Omaha

Sponsor Feasibility Report

Trust Score: 20/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for GU Research Network/Urology Cancer Center?

GU Research Network/Urology Cancer Center has a Crixeo Trust Score of 20/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has GU Research Network/Urology Cancer Center conducted?

GU Research Network/Urology Cancer Center has 13 clinical trials on record, with 3 currently active. Their work covers Metastatic Castration-Resistant Prostate Cancer, UC (Urothelial Cancer), Renal Cell Carcinoma.

Is GU Research Network/Urology Cancer Center accredited by Crixeo Clinical Trials?

GU Research Network/Urology Cancer Center has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about GU Research Network/Urology Cancer Center?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.